Stay hydrated by drinking water, electrolyte drinks, or broth
The data were processed via Biacore T200 Evaluation Software v3.2 (Cytiva) and 1:1 binding model analysis
Was the dose comparable to what the product contains
Findings from the Galbraith plot did not identify any influential studies or outliers, further demonstrating the robustness of the results (Supplementary Fig
Each treatment plan is personalised and may combine GLP-1-based therapies where clinically appropriate, structured nutrition guidance, and non-surgical body contouring to support safe, sustainable, and long-term fat loss
To enhance bioavailability in the market, which is now 1% instead of the 5-10% of oral therapies, pharmaceutical companies are now developing various next-generation oral delivery platforms including enteric-coated formulations, nanoparticle carriers, and absorption enhancers, to make oral GLP-1 therapy more feasible and cost-effective